companydata.dkcompanydata.dk

FERTIN PHARMA A/S: Financial statements 2024

CVR: 25834844

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

FERTIN PHARMA A/S (CVR 25834844) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 1,104,175,000 and a net result of DKK -259,011,000 compared with DKK -136,701,000 the year before. That is an increase of 9% compared with the year before. The profit margin was -23.5%. Equity in the 2024 report amounted to DKK 1,503,550,000. The solvency ratio was 58.5%. The company had 690 employees in the financial year.

Revenue
DKK 1,104,175,000
Gross Profit
DKK 99,947,000
Profit/Loss
DKK -259,011,000
Equity
DKK 1,503,550,000
Total Assets
DKK 2,570,785,000
Employees
690

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20241.1B99.9M-259M1.5B690
20231B34.1M-136.7M458.4M654
2022892.6M25.2M-91.4M596.3M622
2021932.5M161.4M37.6M681.4M569
2020991.1M246.4M155.4M770.1M674

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

FERTIN PHARMA A/S: The 2023 annual report is outJun 11, 2024

FERTIN PHARMA A/S has published its annual report for 2023. Revenue came to DKK 1,012,566,000, and the net result was DKK -136,701,000.

Gitte Lorenzen joins the board of FERTIN PHARMA A/SMay 27, 2024

As of May 27, 2024, Gitte Lorenzen has joined the board of directors of FERTIN PHARMA A/S.

Stine Borup Hvam joins the board of FERTIN PHARMA A/SMay 27, 2024

As of May 27, 2024, Stine Borup Hvam has joined the board of directors of FERTIN PHARMA A/S.

Anita Christensen Lindahl joins the board of FERTIN PHARMA A/SMay 27, 2024

As of May 27, 2024, Anita Christensen Lindahl has joined the board of directors of FERTIN PHARMA A/S.

Bente Brændshøj leaves the board of FERTIN PHARMA A/SMay 27, 2024

As of May 27, 2024, Bente Brændshøj has left the board of directors of FERTIN PHARMA A/S.

Peter Andreas Lund Dahl Jacobsen leaves the board of FERTIN PHARMA A/SMay 27, 2024

As of May 27, 2024, Peter Andreas Lund Dahl Jacobsen has left the board of directors of FERTIN PHARMA A/S.

Gitte Lorenzen leaves the board of FERTIN PHARMA A/SMay 26, 2024

As of May 26, 2024, Gitte Lorenzen has left the board of directors of FERTIN PHARMA A/S.

About FERTIN PHARMA A/S

FERTIN PHARMA A/S is a Danish company of the type Aktieselskab based in Vejle, founded in 2001. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The company was previously named JUT NR. 2128 A/S. The management consists of Michael Henrik Thomsen. The board consists of Christopher Beck Lambert (chair), Bo Korsgaard Jensen, Jovana Mejri and Michael Henrik Thomsen. The company is owned by Aspeya Inc.. The company has 959 employees (2026). In 2025, the company reported revenue of DKK 1,344,394,000 and a net result of DKK -280,841,000 compared with DKK -259,011,000 the year before. Equity in the 2025 report amounted to DKK 1,269,900,000.

Source: annual report 2025, Danish Business Authority